ACTIVE LEARNING TEMPLATE: Medication
Alexis Montz
STUDENT NAME _____________________________________
rivastigmine (Exelon)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
cholinesterase inhibitor/antidementia
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
may slow decline of cognitive function by treats mild to moderate Alzheimer's-type
increasing acetylcholine concentration at dementia
cholinergic transmission sites
Complications Medication Administration
severe or ongoing vomiting or diarrhea,loss of appetite,weight loss,bloody or tarry
stools,cough with bloody mucus,vomit that looks like coffee
PO
grounds,lightheadedness,tremors,restless muscle movements in your eyes, tongue,
jaw or neck,seizure,painful or difficulty urination,severe skin redness,itching,skin
irritation,feeling very thirsty or hot,inability to urinate,heavy sweating, and
hot and dry skin
Contraindications/Precautions
Hepatic Impairment, hx CVD, HTN, use with anesthesia,
peptic ulcers, GI bleeding, seizures, extrapyramidal Nursing Interventions
symptoms; driving or use of machinery
Assess CV, GI, Neuro,
Pulmonary; Caution with
pregnancy and lactation;
Monitor and assess for OD
Interactions prevention
allergy, Metoclopramide, Cholinomimetic And
Anticholinergic Medications, Beta-Blockers
Client Education
Caution with pregnancy and
Evaluation of Medication Effectiveness lactation, report any new sx to
HCP, Report
reduced sx of dementia, signs of slowed decline in tachycardia/bradycardia and
cognitive function HTN or hypotension to your
HCP; May cause impairment in
driving or use of machinery
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
Alexis Montz
STUDENT NAME _____________________________________
rivastigmine (Exelon)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
cholinesterase inhibitor/antidementia
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
may slow decline of cognitive function by treats mild to moderate Alzheimer's-type
increasing acetylcholine concentration at dementia
cholinergic transmission sites
Complications Medication Administration
severe or ongoing vomiting or diarrhea,loss of appetite,weight loss,bloody or tarry
stools,cough with bloody mucus,vomit that looks like coffee
PO
grounds,lightheadedness,tremors,restless muscle movements in your eyes, tongue,
jaw or neck,seizure,painful or difficulty urination,severe skin redness,itching,skin
irritation,feeling very thirsty or hot,inability to urinate,heavy sweating, and
hot and dry skin
Contraindications/Precautions
Hepatic Impairment, hx CVD, HTN, use with anesthesia,
peptic ulcers, GI bleeding, seizures, extrapyramidal Nursing Interventions
symptoms; driving or use of machinery
Assess CV, GI, Neuro,
Pulmonary; Caution with
pregnancy and lactation;
Monitor and assess for OD
Interactions prevention
allergy, Metoclopramide, Cholinomimetic And
Anticholinergic Medications, Beta-Blockers
Client Education
Caution with pregnancy and
Evaluation of Medication Effectiveness lactation, report any new sx to
HCP, Report
reduced sx of dementia, signs of slowed decline in tachycardia/bradycardia and
cognitive function HTN or hypotension to your
HCP; May cause impairment in
driving or use of machinery
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
